Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Alpha1-antichymotrypsin (ACT: new identification SERPINA3) is a member of the serine proteinase inhibitor (serpin) gene family and biochemically has been shown to be a constituent of the senile plaques of Alzheimer's disease.
|
11702211 |
2001 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
|
10559561 |
2000 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Apolipoprotein E (APOE) genotypes did not independently affect blood ACT levels in both AD and controls; although, among AD patients, female AD patients with APOE 4,4 showed the highest level of serum ACT.
|
10629358 |
2000 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The expression of alpha(1)-antichymotrypsin (ACT) is significantly enhanced in affected brain regions in Alzheimer's disease.
|
11027208 |
2000 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In addition, polymorphisms in the signal peptide and 5' of the AACT gene have been reported to increase the risk of developing AD.
|
10713585 |
2000 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.
|
10940674 |
2000 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To evaluate the genetic factors for AD among a Chinese population in Taiwan, we studied the polymorphisms of six candidate genes of Alzheimer's disease (AD), including the regulatory region of apolipoprotein E (Apo-E, G-186T), the promoter of apolipoprotein E (Apo-E, A-491T), the bleomycin hydrolase gene (BH, A1450G), a mutation of alpha(2)-macroglobulin gene (A2M G2998A), low-density lipoprotein receptor-related protein gene (LRP, C766T), and alpha(1)-antichymotrypsin gene (ACT, -15Ala/Thr) in AD patients and non-affected elder individuals among Taiwanese Chinese.
|
11099722 |
2000 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The presence of the apolipoprotein E4 allele (ApoE4) did not correlate with the ACT-A allele, as previously reported, and appeared to be independent of the risk for developing AD.
|
11132933 |
2000 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
|
10766998 |
2000 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) and DNA sequencing were employed to screen the coding region of the alpha-antichymotrypsin (AACT) gene in Han-Chinese population for polymorphism possibly associated with Alzheimer's disease (AD).
|
10980547 |
2000 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
(1,2) However, it is unknown whether the increased expression of alpha(1)-antichymotrypsin found in AD brains counteracts or contributes to the disease.
|
11106573 |
2000 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic association study between alpha 1-antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population.
|
10893483 |
2000 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease.
|
10487844 |
1999 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Alzheimer disease (AD) patients with both sporadic and familial forms of AD and non-demented controls were genotyped for common polymorphisms in the signal peptide for alpha-1-antichymotrypsin (ACT) gene and in two different regions of apolipoprotein E (APOE) gene.
|
10462111 |
1999 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Chinese.
|
10474059 |
1999 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
It has been suggested that polymorphisms at the genes for presenilin-1 (PS-1) and alpha-1-antichymotrypsin (ACT) confer an increased risk for AD in the general population, and therefore potentially to AD in people with DS.
|
10581479 |
1999 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently, it was reported that the position-15 (alanine) polymorphism of the alpha1-antichymotrypsin gene (ACT*A) was a risk factor for Alzheimer's disease.
|
10622342 |
1999 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A common polymorphism in the alpha1-antichymotrypsin (ACT) gene is associated with Alzheimer's disease.
|
10474060 |
1999 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with alzheimer-type neuropathological changes or sporadic Alzheimer's disease.
|
10325450 |
1999 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The AACT A allele is not a major risk factor for late-onset AD or DLB.
|
9484359 |
1998 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease.
|
9749607 |
1998 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A common polymorphism in the alpha1-antichymotrypsin (ACT) gene has been shown to modify the Apolipoprotein E (ApoE) epsilon4-associated Alzheimer's disease (AD) risk identifying the combination of the ACT/AA and ApoE epsilon4/epsilon4 genotypes as a potential susceptibility marker for AD.
|
9572591 |
1998 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Elevated ACT levels in the brain of AD patients could be interpreted as a metabolic response of astrocytes which might modulate the potentially deleterious activation of microglia cells.
|
9688331 |
1998 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
These data suggest that the etiological basis of PD might be partly similar to that of AD and the ACT gene might be one of the susceptibility factors for PD.
|
9219874 |
1997 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.
|
9153464 |
1997 |